QNTM (Quantum BioPharma) Cyclically Adjusted Book per Share: $128.27 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

QNTM Quantum BioPharma Ltd QNTM
21 GF Score
Price $2.95
! 4 Warning Signs
View Full Analysis

What is Quantum BioPharma Cyclically Adjusted Book per Share?

Quantum BioPharma QNTM -5.45% 21 Cyclically Adjusted Book per Share is $128.27 as of Jun. 2026. GuruFocus rates QNTM with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Quantum BioPharma's adjusted book value per share for the three months ended in Jun. 2026 was $1.049. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $128.27 for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-09-04), Quantum BioPharma's current stock price is $2.95. Quantum BioPharma's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $128.27. Quantum BioPharma's Cyclically Adjusted PB Ratio of today is 0.02.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Quantum BioPharma was 0.02. The lowest was 0.00. And the median was 0.00.


Quantum BioPharma  (NAS:QNTM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Quantum BioPharma's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=2.95/128.27
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Cyclically Adjusted PB Ratio of Quantum BioPharma was 0.02. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Quantum BioPharma Cyclically Adjusted Book per Share Related Terms


Quantum BioPharma Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Quantum BioPharma's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Quantum BioPharma Cyclically Adjusted Book per Share Chart

Quantum BioPharma Annual Data
Trend Aug16 Aug17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 127.17

Quantum BioPharma Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 127.17 134.81 128.27

QNTM vs VRTX, REGN, MRNA: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Quantum BioPharma's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum BioPharma Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum BioPharma's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Quantum BioPharma's Cyclically Adjusted PB Ratio falls into.


QNTM
21GF Score
Quantum BioPharma Ltd QNTM
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Quantum BioPharma Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Quantum BioPharma's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.049/133.5265*133.5265
=1.049

Current CPI (Jun. 2026) = 133.5265.

Quantum BioPharma Quarterly Data

Book Value per Share CPI Adj_Book
201608 -0.535 101.686 -0.703
201611 0.000 101.607 0.000
201702 0.000 102.476 0.000
201705 -0.653 103.108 -0.846
201708 -0.752 103.108 -0.974
201711 -0.782 103.740 -1.007
201802 17.050 104.688 21.747
201806 395.168 105.557 499.876
201809 493.346 105.636 623.601
201812 356.838 105.399 452.066
201903 349.726 106.979 436.512
201906 439.629 107.690 545.101
201909 386.633 107.611 479.743
201912 297.352 107.769 368.420
202003 225.865 107.927 279.438
202006 213.682 108.401 263.209
202009 139.461 108.164 172.162
202012 123.081 108.559 151.388
202103 123.657 110.298 149.699
202106 105.766 111.720 126.411
202109 96.707 112.905 114.370
202112 87.027 113.774 102.136
202203 78.986 117.646 89.648
202206 72.051 120.806 79.638
202209 61.677 120.648 68.261
202212 51.591 120.964 56.949
202303 34.762 122.702 37.829
202306 25.872 124.203 27.814
202309 24.482 125.230 26.104
202312 21.843 125.072 23.319
202403 19.341 126.258 20.454
202406 15.032 127.522 15.740
202409 8.739 127.285 9.168
202412 4.992 127.364 5.234
202503 2.115 129.181 2.186
202506 1.085 129.892 1.115
202509 2.267 130.287 2.323
202512 1.781 130.366 1.824
202603 0.102 132.262 0.103
202606 1.049 133.527 1.049

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $128.27 mean?
Quantum BioPharma (QNTM) has a Cyclically Adjusted Book per Share of $128.27 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Quantum BioPharma and its competitors.
Is Quantum BioPharma's Cyclically Adjusted Book per Share too high?
Quantum BioPharma's current Cyclically Adjusted Book per Share is $128.27. Overall, Quantum BioPharma has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Quantum BioPharma's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Quantum BioPharma's Cyclically Adjusted Book per Share of $128.27 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Quantum BioPharma and its competitors. Quantum BioPharma's current Cyclically Adjusted Book per Share is $128.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum BioPharma stock overvalued right now?
Quantum BioPharma (QNTM) has a current Cyclically Adjusted Book per Share of $128.27. The current Cyclically Adjusted Book per Share is $128.27. Quantum BioPharma's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Quantum BioPharma (QNTM), the current Cyclically Adjusted Book per Share is $128.27 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Quantum BioPharma Business Description

Other Exchanges 0K91:GermanyQNTM:Canada
Address 1 Adelaide Street East, Suite 801, Toronto, ON, CAN, M5C 2V9
Quantum BioPharma Ltd is a biopharmaceutical company dedicated to building a portfolio of inventive assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, it is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, which represents loans secured by residential or commercial property.
21GF Score

Get the complete analysis for QNTM

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.95
Price